M01 Management of Classic Congenital Adrenal Hyperplasia: from Birth to Adulthood

Program: Meet-the-Professor Sessions
Clinical Session
Friday, April 1, 2016: 2:15 PM-3:00 PM
BR West (BCEC)
Friday, April 1, 2016: 3:30 PM-4:15 PM
BR West (BCEC)
Speaker:
Maria G Vogiatzi, MD, Children's Hospital of Philadelphia, Philadelphia,

Disclosures:
MGV: Advisory Group Member, Novo Nordisk.

Still controversy regarding optimal treatment regimens, biochemical targets, endocrine outcomes and growth in children with CAH

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire